Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Oncotarget|May 2, 2019
Micrometastasis of endometriosis to distant organs in a murine modelElham N Samani, Ramanaiah Mamillapalli, Fei Li, et al.
Journal of Cellular and Molecular Medicine|October 7, 2014
Endometrial stem cell transplantation in MPTP- exposed primates: an alternative cell source for treatment of Parkinson's diseaseErin F Wolff, Levent Mutlu, Efi E Massasa, et al.
Gynecologic Oncology Reports|January 10, 2022
Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sitesJessie Y Li, Levent Mutlu, Joan Tymon-Rosario, et al.
International Journal of Molecular Sciences|May 27, 2023
Monitoring Treatment Response, Early Recurrence, and Survival in Uterine Serous Carcinoma and Carcinosarcoma Patients Using Personalized Circulating Tumor DNA BiomarkersStefania Bellone, Blair McNamara, Levent Mutlu, et al.
Gynecologic Oncology|July 9, 2024
Preclinical activity of datopotamab deruxtecan, a novel TROP2 directed antibody-drug conjugate targeting trophoblast cell-surface antigen 2 (TROP2) in ovarian carcinomaBlair McNamara, Michelle Greenman, Stefania Bellone, et al.
Gynecologic Oncology|May 4, 2024
Preclinical in vitro and in vivo activity of the RAF/MEK clamp avutometinib in combination with FAK inhibition in uterine carcinosarcomasCem Demirkiran, Michelle Greenman, Stefania Bellone, et al.
Annals of Surgical Oncology|June 26, 2023
Hyperthermic Intraperitoneal Chemotherapy in Ovarian CancerJulia H Gelissen, Naomi N Adjei, Blair McNamara, et al.
Gynecologic Oncology|March 16, 2024
Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancerBlair McNamara, Cem Demirkiran, Tobias Max Philipp Hartwich, et al.
Gynecologic Oncology|January 27, 2023
The Poly (ADP-ribose) polymerase inhibitor olaparib and pan-ErbB inhibitor neratinib are highly synergistic in HER2 overexpressing epithelial ovarian carcinoma in vitro and in vivoChanhee Han, Blair McNamara, Stefania Bellone, et al.
Gynecologic Oncology|May 31, 2022
Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neuGhanshyam Yadav, Dana M Roque, Stefania Bellone, et al.
Pageof 4